process
viru
replic
host
cell
greatli
influenc
set
cytokin
chemokin
antivir
substanc
activ
result
hostviru
interact
alter
cytokin
profil
manipul
innat
immun
system
innat
immun
stimul
may
help
inhibit
viru
replic
otherwis
permiss
cell
aim
present
studi
character
innat
immun
respons
capabl
inhibit
infecti
bronchiti
viru
ibv
replic
chicken
lung
ovo
administr
cpg
odn
experi
cpg
odn
pb
solut
inject
embryon
day
ed
via
chorioallonto
rout
cpg
odn
pb
inocul
embryo
challeng
virul
ibv
ed
lung
tissu
sampl
experiment
chick
analys
cytokineschemokin
gene
express
h
h
h
post
infect
data
show
signific
differenti
upregul
gene
suppress
gene
express
associ
inhibit
ibv
replic
lung
tissu
retriev
embryo
pretreat
cpg
odn
expect
understand
innat
immun
modul
target
tissu
viru
innat
immun
stimul
help
identif
valuabl
target
develop
novel
safe
effect
econom
control
strategi
ibv
infect
chicken
natur
innat
cellular
immun
respons
thelper
th
th
activ
result
viru
interact
host
cell
play
crucial
role
outcom
viral
infect
interact
lead
induct
differ
cytokin
chemokin
antimicrobi
substanc
regul
process
viru
replic
host
cell
estcourt
et
al
et
al
noteworthi
cytokineschemokin
induc
virus
may
lead
activ
disproportion
inflammatori
respons
damag
host
tissu
may
compromis
physiolog
function
affect
tissu
instanc
death
infect
noninfect
cell
site
mous
hepat
viru
mhv
infect
mice
attribut
increas
influx
proinflammatori
cell
excess
induct
interleukin
il
mediat
activ
mitogenactiv
protein
kinas
pathway
banerje
et
al
perlman
dandekar
contrast
amplifi
express
cytokin
sever
acut
respiratori
syndrom
sar
coronaviru
cov
infect
cell
trigger
function
modif
macrophag
dendrit
cell
steer
strengthen
host
innat
immun
respons
sarscov
infect
sim
et
al
yoshikawa
et
al
similarli
protect
mice
presensit
respiratori
syncyti
viru
rsv
f
protein
mediat
activ
cell
lead
increas
product
interferon
ifn
cytokin
contrast
mice
vaccin
rsv
g
protein
exhibit
pulmonari
eosinophilia
aggrav
diseas
symptom
associ
enhanc
express
lung
andrew
et
al
estcourt
et
al
hogan
et
al
interestingli
rsv
induc
lung
patholog
due
product
cytokin
accumul
eosinophil
lung
may
suppress
administr
recombin
increas
product
mediat
activ
cd
cell
hogan
et
al
likewis
elev
express
hepat
b
viru
hbv
infect
link
clearanc
viru
bodi
cavanaugh
et
al
rossol
et
al
find
suggest
understand
molecular
basi
immun
modul
virus
innat
immun
modul
may
help
develop
effect
therapeut
prophylact
strategi
infecti
diseas
human
anim
fearon
coronavirus
caus
seriou
diseas
includ
sar
human
transmiss
porcin
gastroenter
pig
calf
scour
bovin
felin
infecti
periton
cat
mous
hepat
mice
avian
infecti
bronchiti
bird
tanaka
et
al
avian
infecti
bronchiti
caus
ibv
highli
contagi
respiratori
diseas
commerci
chicken
ibv
infect
caus
huge
econom
loss
term
high
morbid
mortal
viral
strain
low
egg
qualiti
product
loss
broiler
layer
breeder
chicken
banat
et
al
addit
rapid
emerg
new
strain
lack
cross
protect
amongst
differ
serotyp
nonavail
vaccin
differ
variant
ibv
matter
seriou
concern
poultri
industri
jackwood
et
al
lee
jackwood
therefor
develop
strategi
potenti
effect
across
multipl
serotyp
need
control
ibv
coronaviru
infect
anim
human
regard
recent
demonstr
ovo
administr
unmethyl
deoxycytidyldeoxyguanosin
cpg
dinucleotid
rel
common
bacteri
viral
dna
trigger
immun
modulatori
event
inhibit
ibv
replic
chicken
lung
trachea
spleen
kidney
tissu
dar
et
al
b
data
studi
shown
import
clinic
potenti
cpg
odn
vaccin
adjuv
therapeut
agent
coronaviru
infect
chicken
howev
studi
n
gene
express
ibv
analys
describ
organ
aim
present
studi
investig
mechanist
detail
innat
immun
respons
activ
lung
ovo
cpg
odn
treatment
follow
ibv
infect
chicken
expect
understand
basi
innat
immun
modul
target
tissu
virus
cpg
odn
help
identif
valuabl
target
develop
novel
safe
effect
econom
control
strategi
ibv
infect
chicken
moreov
cpg
odn
may
serv
univers
prophylact
reagent
viru
specif
vaccin
develop
control
ibv
infect
chicken
addit
lesson
learn
studi
may
instruct
develop
vaccin
coronaviru
infect
human
anim
anim
experi
specif
pathogen
free
spf
egg
synthet
cpg
odn
tcgtcgttgtcgttttgtcgtt
phosphorothio
backbon
merial
ltd
athen
ga
use
ovo
safeti
innat
immun
activ
potenti
cpg
odn
previous
report
us
research
dar
et
al
gomi
et
al
gomi
et
al
embryon
day
ed
egg
randomli
divid
three
equal
group
ac
embryo
group
inject
l
cpg
odn
solut
steril
pb
g
odnl
via
chorioallonto
rout
embryo
group
b
c
given
l
steril
pb
pb
ph
sigmaaldrich
st
loui
mo
via
chorioallonto
rout
addit
first
experi
addit
group
ad
embryo
group
group
given
l
cpg
odn
solut
steril
pb
g
odnl
via
chorioallonto
rout
ed
embryo
group
b
infect
via
chorioallonto
rout
l
ibv
solut
contain
embryo
infecti
dose
eid
embryo
group
c
infect
ibv
lung
tissu
sampl
collect
infect
noninfect
embryo
chick
h
h
h
post
infect
pi
similarli
lung
tissu
sampl
group
collect
h
h
h
post
cpg
inocul
ibv
replic
evalu
time
depend
increas
ibv
nucleocapsid
n
gene
express
cellular
rna
extract
infect
tissu
tissu
sampl
collect
trizol
invitrogen
carlsbad
ca
rna
extract
per
manufactur
instruct
extract
rna
quantifi
check
qualiti
use
agil
rna
nano
labchip
kit
agil
technolog
waldbronn
germani
prior
cdna
synthesi
rna
sampl
treat
dnase
invitrogen
h
c
primer
use
studi
shown
tabl
wherea
paramet
revers
transcript
realtim
pcr
assay
follow
previous
describ
dar
et
al
briefli
g
dnase
treat
rna
isol
lung
tissu
use
templat
synthesi
cdna
tabl
list
primer
use
studi
sequenc
random
hexam
primer
superscript
ii
revers
transcriptas
invitrogen
use
revers
transcript
rna
differenti
mrna
express
evalu
use
icycl
iq
iq
sybr
green
supermix
biorad
hercul
ca
target
gene
sampl
run
parallel
plate
normal
ct
valu
ct
valu
cycl
number
fluoresc
due
amplif
target
dna
reach
significantli
background
target
gene
use
assess
chang
mrna
express
first
normal
ct
ct
valu
gene
subtract
ct
valu
target
gene
second
normal
ct
done
subtract
mean
ct
valu
noninfect
pbstreat
tissu
cell
ct
valu
ibv
infect
tissu
cell
increas
decreas
target
gene
mrna
level
infect
tissu
cell
compar
pb
treat
non
infect
tissu
cell
calcul
asfold
chang
increas
ct
livak
schmittgen
four
experi
experi
repeat
four
time
tissu
sampl
three
embryo
treatment
time
point
pool
gener
one
sampl
sampl
run
triplic
qpcr
plate
target
mrna
along
mrna
dnasetr
rna
sampl
without
convers
rna
cdna
templat
pcr
control
run
triplic
plate
experi
mean
ct
valu
three
well
taken
final
ct
valu
data
analys
use
excel
microsoft
redmond
wa
graphpad
prism
tm
softwar
graphpad
softwar
inc
san
diego
ca
final
data
express
mean
sem
offold
chang
observ
experi
data
normal
log
transform
differ
infold
chang
mrna
express
calcul
use
one
way
analysi
varianc
tukey
multipl
comparison
post
test
result
assum
statist
signific
p
order
evalu
statu
viru
replic
cpg
odn
pretreat
pb
treat
embryo
analys
express
viral
nucleocapsid
n
gene
embryon
lung
h
h
h
post
ibv
infect
data
show
significantli
lower
level
viral
n
gene
express
group
embryo
treat
cpg
odn
prior
infect
fig
data
show
equal
level
gene
upregul
fold
increas
express
h
post
infect
cpg
pretreat
noncpg
treat
infect
group
group
b
contrast
gene
express
embryon
lung
tissu
treat
cpg
odn
prior
ibv
infect
significantli
higher
fold
compar
noncpg
treat
infect
group
h
h
h
post
infect
fig
gene
express
show
signific
differ
cpg
odn
treat
group
pb
treat
group
b
ibv
infect
embryo
fig
b
surprisingli
gene
express
significantli
upregul
non
cpg
treat
infect
embryo
group
b
h
pi
gene
show
significantli
higher
express
group
embryo
pretreat
cpg
odn
group
compar
pb
treat
group
b
embryo
h
post
ibv
challeng
fig
b
analys
express
two
chemotact
cytokin
macrophag
inflammatori
protein
mip
chemokin
gene
show
significantli
higher
express
cpg
odn
pretreat
infect
embryo
compar
pb
pretreat
infect
embryo
h
pi
howev
differ
gene
express
b
group
fig
experi
nonsignific
differ
oasa
gene
express
cpg
odn
pretreat
pb
pretreat
infect
embryo
group
b
respect
first
h
pi
howev
h
pi
oasa
gene
express
embryon
lung
cpg
odn
pretreat
group
significantli
lower
lung
pb
treat
embryo
fig
analysi
lung
tissu
collect
group
h
post
cpg
odn
administr
show
substanti
upregul
fold
gene
express
moder
level
increas
fold
fold
fold
oasa
fold
gene
express
observ
noteworthi
h
post
cpg
odn
administr
time
point
time
point
embryo
group
b
challeng
ibv
tabl
initi
interact
viral
surfac
protein
cellular
receptor
lead
first
wave
cytokin
product
mogensen
paludan
wherebi
cytokin
exhibit
activ
format
antivir
protein
shape
adapt
immun
samuel
spiegel
weber
altern
virus
evolv
variou
mechan
alter
host
defenc
favour
viru
propag
interestingli
immun
evas
process
facilit
modul
cytokineschemokin
induct
process
host
cell
cheung
et
al
huang
et
al
reghunathan
et
al
wang
et
al
amongst
cytokin
interferon
larg
famili
secret
protein
involv
innat
antivir
activ
regul
cell
growth
adapt
immun
respons
activ
hook
et
al
type
interferon
ifn
cytokin
produc
major
bodi
cell
respons
viral
infect
expect
b
class
cpg
odn
administr
cpg
odn
chicken
embryo
induc
low
level
ifn
gene
express
lung
tabl
howev
approxim
fold
upregul
gene
express
cpg
odn
treat
non
cpg
odn
treat
embryo
group
b
infect
ibv
seen
studi
suggest
increas
express
gene
may
associ
ibv
infect
data
also
impli
upregul
gene
express
may
implic
ibv
replic
vivo
chicken
lung
altern
may
also
assum
fold
upregul
gene
express
vivo
may
suffici
effect
ibv
replic
lung
cell
noteworthi
similar
find
nonsignific
upregul
interferon
gene
sarscov
infect
individu
experiment
infect
mice
observ
research
glass
et
al
reghunathan
et
al
howev
vitro
inhibitori
effect
type
interferon
sarscov
replic
report
research
yoshikawa
et
al
find
indic
coronaviru
evolv
strategi
evad
import
innat
host
defenc
vivo
moreov
recent
found
n
protein
sar
coronavirus
antagonist
effect
activ
type
relat
pathway
kopeckybromberg
et
al
narayanan
et
al
spiegel
et
al
tohya
et
al
key
immuneregulatori
type
ii
interferon
mainli
synthes
immun
cell
includ
natur
killer
cell
lymphocyt
respons
mitogen
antigen
stimuli
young
bream
young
ghosh
mediat
antivir
activ
multilevel
cellular
interact
bind
receptor
lead
chang
mrna
express
compar
cpg
odn
pretreat
pb
pretreat
group
shown
mean
sem
fold
chang
gene
express
differ
mrna
express
consid
signific
p
indic
differ
superscript
alphabet
b
bar
b
mrna
stimul
lung
tissu
cytokin
mrna
express
lung
tissu
follow
cpg
odn
pb
administr
day
old
chicken
embryo
via
chorioallonto
rout
embryo
infect
ibv
via
chorioallonto
rout
embryon
day
chang
mrna
express
compar
cpg
odn
pretreat
pb
pretreat
group
shown
mean
sem
fold
chang
gene
express
differ
mrna
express
consid
signific
p
indic
differ
superscript
alphabet
b
bar
activ
signal
transduct
activ
transcript
stat
two
member
janu
famili
tyrosin
kinas
activ
jakstat
signal
pathway
primarili
involv
signal
transduct
activ
immun
respons
gene
includ
gene
hurgin
et
al
also
activ
cell
monocyt
resid
cell
lead
enhanc
cell
cytox
granzym
b
mhc
ii
induct
variou
research
shown
highli
increas
suscept
mous
hepat
schijn
et
al
likewis
regul
cellular
adhes
molecul
icam
gene
express
mediat
activ
gene
express
led
increas
resist
rhinoviru
infect
mice
bianco
et
al
sethi
et
al
chicken
induct
incorpor
vaccin
adjuv
shown
signific
antivir
activ
mediat
enhanc
mhc
gene
express
antigen
present
cell
stimul
antibodi
product
promot
antibodi
isotyp
switch
rapid
develop
cytotox
cell
hackney
et
al
lowenth
et
al
b
harmoni
find
inhibit
ibv
replic
signific
upregul
gene
express
cpg
odn
pretreat
ibv
infect
group
studi
suggest
cpg
odn
may
consid
potenti
adjuv
candid
noninvas
vaccin
ibv
infect
well
known
sever
sarscov
infect
augment
elev
express
inflammatori
mediat
includ
interferon
induc
protein
ip
monocyt
chemoattract
protein
mcp
huang
et
al
jiang
et
al
reghunathan
et
al
tseng
et
al
yoshikawa
et
al
zhang
et
al
similar
sarscov
ibv
infect
multipl
tissu
system
includ
lung
kidney
gi
tract
cavanagh
major
clinic
sign
sever
respiratori
infect
ibv
includ
mucos
thicken
accumul
thick
mucu
believ
similar
respiratori
virus
induct
cytokin
includ
ibv
infect
epitheli
cell
contribut
toward
excess
mucu
product
hendley
base
find
suppress
gene
express
group
experi
may
suggest
antiinflamatori
role
cpg
odn
ibv
infect
howev
investig
need
regard
similarli
well
known
chemoattract
heterophil
abundantli
found
nasal
exud
ibv
infect
bird
increas
express
associ
inhibit
ibv
replic
lung
cpg
odn
treat
group
agreement
enhanc
express
sarscov
infect
cell
lead
function
modif
macrophag
dendrit
cell
strengthen
host
innat
immun
respons
sim
et
al
yoshikawa
et
al
guo
et
al
kimura
et
al
shown
activ
ifn
signal
pathway
critic
bridg
innat
adapt
immun
induct
antivir
state
ibv
respiratori
virus
infect
guo
et
al
kimura
et
al
signific
induct
gene
cpg
odn
treat
ibv
infect
group
experi
may
suggest
similar
antivir
role
cytokin
activ
oa
ribonucleas
rnase
l
part
import
host
antivir
pathway
activ
rnase
l
well
know
function
oa
activ
rnase
l
inhibit
viral
replic
degrad
singl
strand
viral
cellular
rna
block
protein
synthesi
silverman
zhao
et
al
high
level
oasa
gene
express
cpg
treat
noncpg
treat
infect
lung
first
h
pi
suggest
activ
oa
ibv
infect
cell
effect
viru
replic
may
assum
similar
mani
virus
ibv
evolv
strategi
block
oasa
antivir
pathway
downstream
activ
oa
instanc
zhao
et
al
zhang
et
al
report
protein
mous
hepat
viru
coronaviru
abil
prevent
rnase
l
activ
cleavag
oa
protein
zhang
et
al
zhao
et
al
similarli
rna
structur
present
open
read
frame
orf
viral
proteas
gene
pro
polio
viru
infect
act
potent
rnase
l
inhibitor
prevent
viral
rna
degrad
rnase
l
han
et
al
virus
includ
encephlomyocard
viru
inhibit
rnase
l
activ
activ
rnase
l
inhibitor
rli
protein
martinand
et
al
martinand
et
al
addit
significantli
reduc
oasa
gene
express
cpg
odn
treat
lung
compar
pb
treat
group
h
pi
may
due
lack
viru
replic
cpg
treat
cell
wherea
significantli
higher
express
oasa
gene
noncpg
treat
infect
lung
may
associ
continu
ibv
replic
conclus
data
demonstr
signific
role
differenti
upregul
gene
suppress
gene
express
inhibit
ibv
replic
chicken
lung
character
marker
gen
help
improv
theraput
prophylact
reagent
control
coronaviru
infect
